Titlebook: Image Analysis; 13th Scandinavian Co Josef Bigun,Tomas Gustavsson Conference proceedings 2003 Springer-Verlag GmbH Germany, part of Springe

咽下

S?ren I. Olsenarcinomas than in normal mucosa. The lectin binding pattern of adenomas was similar to that of the transitional mucosa. However, in proliferating parts and areas with cell atypia the amount of lectin receptors was generally reduced. In colonic carcinomas the occurrence of lectin receptors was correl

溫和女孩

Erik Liengence of this tumor is only 0.2/100,000. However, the propensity for adrenal cortical carcinoma to excrete hormones has led to unique groups of drugs which produce significant palliation of bothersome and life-threatening endocrinologically induced symptoms. Cushing’s syndrome, virilization, feminiza

judiciousness

Herbert Tesser,Theron Trouttients. Yet enthusiasm for these successes has, in part, been offset by the problems in evaluating responses to treatment and by the disappointment of failing to check the progress of still so many other tumours. These reactions will be no surprise to the medical historian but perhaps the expectatio

gene-therapy

蜿蜒而流

集合

因無茶而冷淡

Bruno Merven,Fred Nicolls,Gerhard de Jageround in almost all the B cells and most B-lymphoid malignancies including non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL)..Inotuzumab ozogamicin (INO) is one of the antibody-drug conjugates (ADCs) that consists of a cytotoxic drug, calicheamicin, attached to a humanized monoclonal

nitroglycerin

Jana Kostková,Jan ?ech,Radim ?áraound in almost all the B cells and most B-lymphoid malignancies including non-Hodgkin lymphoma (NHL) and acute lymphoblastic leukemia (ALL)..Inotuzumab ozogamicin (INO) is one of the antibody-drug conjugates (ADCs) that consists of a cytotoxic drug, calicheamicin, attached to a humanized monoclonal

戰(zhàn)勝

Lars B. B??thiveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years. This improvement has been made possible with the development of molecular targeted agents such as bcr-abl tyrosine kinase inhibitors and all-trans retinoic acid. The ant

兇兆